Growing evidence supports the neurotoxic effects of tau as a primary event for neuron loss and synaptic injury, both of which are common neuropathologic manifestations in AD and closely related to the severity of cognitive disfunction (Iqbal and Grundke-Iqbal, 2002; Giannakopoulos et al., 2003). This evidence concerns the gene MAPT and Alzheimer disease.